Iressa 250 mg (Gefitinib TABLET) 250 MG

IRESSA 250 MG tablets contain gefitinib, a medication used to manage certain types of cancer. This oral treatment is designed to target specific cancer cells, offering a targeted approach to therapy. Learn more about gefitinib and its uses here.

Strength

250 MG

Pack Size

Manufacturer / TM Owner

ASTRAZENECA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

IRESSA 250 MG tablets are primarily used in the treatment of specific types of cancer. Gefitinib, the active ingredient, is often prescribed for non-small cell lung cancer (NSCLC) that has spread or returned. This medication works by targeting certain proteins in cancer cells, which can help slow down the growth and spread of the disease. Patients should consult their healthcare provider to determine if gefitinib is suitable for their condition.

Side Effects

Common effects of IRESSA 250 MG tablets may include skin rash, diarrhea, and nausea. Some users might experience appetite loss or dry skin. These effects can vary from person to person, and not everyone will experience them. If any side effects are severe or persistent, it is important to seek medical advice.

Precautions & Warnings

IRESSA 250 MG tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may interact with other treatments, so it is crucial to inform your doctor about all medications you are taking. Pregnant or breastfeeding women should consult their healthcare provider before using gefitinib.

Avoid Interactions

IRESSA 250 MG tablets may interact with certain medications, including those that affect liver enzymes. It is important to avoid grapefruit or grapefruit juice while taking gefitinib, as it can increase the risk of side effects. Always inform your healthcare provider about all medications, supplements, and herbal products you are using to avoid potential interactions.

Frequently Asked Questions

IRESSA 250 MG tablets are used to treat specific types of cancer, particularly non-small cell lung cancer (NSCLC) that has spread or returned.

IRESSA 250 MG tablets are taken orally, typically once daily. Follow the dosage and administration instructions provided by your healthcare provider.

Common side effects may include skin rash, diarrhea, nausea, appetite loss, and dry skin. If these effects are severe or persistent, consult your healthcare provider.

IRESSA 250 MG may interact with other medications, especially those that affect liver enzymes. Always inform your healthcare provider about all medications you are taking.

Pregnant or breastfeeding women should consult their healthcare provider before using IRESSA 250 MG tablets, as the safety of gefitinib in these conditions has not been established.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.